Dr. Basha's research expertise is in the field of experimental therapeutics and cancer. His research focuses on examining aberrant expression of molecular markers associated with aggressive disease and poor prognosis for a variety of human malignancies.
Ongoing research focuses on testing the combination of novel investigational agents with other standard therapeutic options (chemotherapy and/or radiation), and understanding the potential molecular pathways associated with proposed combinations. Novel therapeutic strategies involving small molecules, herbal products, and their analogs are under testing through rigorous pre-clinical screening using models for leukemia, pancreatic, ovarian, prostate, and central nervous system cancers.